CEDARHURST, N.Y., July 27, 2023 /PRNewswire/ — The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of BioXcel Therapeutics, Inc. (NasdaqCM: BTAI), if they purchased the Company’s securities between December 15, 2021 and June 28, 2023, inclusive (the “Class Period”). Shareholders have until September 5,…Read More
FILING DEADLINEKuznicki Law PLLC Announces Class Action on Behalf of Shareholders of BioXcel Therapeutics Inc BTAI
